Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss. Should ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

As weight loss drugs like Ozempic and Mounjaro gain a lot of attention worldwide a new study has revealed a rare side effect ...

Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

New studies indicate that weight-loss drugs may lead to serious eye diseases and vision loss in some individuals, prompting ...

A large-scale cohort study has found that GLP-1s, including Ozempic and Wegovy, may be associated with a modestly increased risk of developing diabetic retinopathy. The research, published Aug. 11 in ...

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye complications ...

Two studies were conducted to verify concerns about diabetic retinopathy that were raised during initial trials of ...

As weight-loss drugs are gaining popularity among Indian diabetes and obesity stricken patients in India, new research ...

A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with ...

EMA says semaglutide may double the risk of NAION, a rare eye condition affecting up to 1 in 10,000 people. Diabetics on GLP-1 drugs for over 30 months had 3x higher risk of advanced macular ...